🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

11 recruiting trials

for Primary Malignant Neoplasm of Prostate (Diagnosis)

MRI-Guided Cryoablation for Focal Native Prostate Cancer NCT04797039n/a1 site📍 Rochester Mayo Clinic · Tests: MR guided cryoablation Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy on Primary Tumor in Addition to Androgen Deprivation Therapy in HOrmone-Sensitive Metastatic Prostate Cancer Patients NCT06473259n/a3 sites📍 Orbassano📍 Padova📍 Trento Santa Chiara Hospital · Tests: Docetaxel, Apalutamide Oral Tablet, Enzalutamide Oral Tablet, Abiraterone acetate tablets, Darolutamide Oral Tablet The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas NCT07285044Phase 21 site📍 Jacksonville Mayo Clinic · Tests: Cancer Therapeutic Procedure, Cancer Therapeutic Procedure, Questionnaire Administration EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors NCT07410676Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: EBNK-001 + IL-15 + Pembrolizumab Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research NCT05539677n/a1 site📍 Saint Petersburg N.N. Petrov National Medical Research Center of Oncology Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy NCT06957691Phase 21 site📍 Boston Shehzad Basaria, M.D. · Tests: fezolinetant - reference formulation, Placebo SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry NCT03452774n/a68 sites📍 Birmingham📍 Mobile📍 Scottsdale Massive Bio, Inc. · Tests: Clinical Trial Matching Collection and Measurement of Biomarkers in Prostate Cancer Radiotherapy Patients NCT02997709n/a1 site📍 Miami University of Miami Different Fractionation Schedules of Radiotherapy to the Primary Tumour in Metastatic Hormone Sensitive Prostate Cancer NCT04612907NA1 site📍 Umeå Umeå University · Tests: Moderate hypo-fractionation, Ultra-hypo-fractionation At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer NCT05969860Phase 22 sites📍 Jacksonville📍 Grand Forks Mayo Clinic · Tests: Clinical Encounter, Home Health Encounter, Quality-of-Life Assessment, Questionnaire Administration Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors NCT07410494Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: EB-SELECT Single-Target CAR-NK Cells, Dual-Target Antigen-Selected CAR-NK
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy